Genetic polymorphisms influencing total and γ' fibrinogen levels and fibrin clot properties in Africans

British Journal of Haematology

Volumn 168, Issue 1, 2015, Pages 102-112

  Kotzé, Retha C ^a   Nienaber Rousseau, Cornelie ^a   De Lange, Zelda ^a   De Maat, Moniek P ^b   Hoekstra, Tiny ^a,c   Pieters, Marlien ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Fibrinogen; Fibrinolysis; Genetics of thrombosis and haemostasis

Indexed keywords

ADENINE; ARGININE; CYTOSINE; FIBRIN; FIBRINOGEN; GAMMA FIBRINOGEN; GUANINE; HISTIDINE; THYMINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN; AGED; ALLELE; ARTICLE; BLOOD CLOTTING; COHORT ANALYSIS; CONTROLLED STUDY; F13A1 GENE; FACTOR XIII GENE; FEMALE; FGA GENE; FGB GENE; FGG GENE; FIBER; FIBRINOGEN GENE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TURBIDIMETRY; BLACK PERSON; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BLOOD COAGULATION; FEMALE; FIBRIN; FIBRINOGEN; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84915764156     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13104     Document Type: Article

References (50)

1. Ajjan, R., Lim, B.C.B., Standeven, K.F., Harrand, R., Dolling, S., Phoenix, F., Greaves, R., Abou-Saleh, R.H., Connell, S., Smith, D.A.M., Weisel, J.W., Grant, P.J. & Ariëns, R.A.S. (2008) Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood, 111, 643-650.
2. Ariëns, R.A.S., Philippou, H., Nagaswami, C., Weisel, J.W., Lane, D.A. & Grant, P.J. (2000) The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood, 96, 988-995.
3. Ariëns, R.A.S., Lai, T., Weisel, J.W., Greenberg, C.S. & Grant, P.J. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood, 100, 743-754.
4. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
5. Behague, I., Poirier, O., Nicaud, V., Evans, A., Arveiler, D., Luc, G., Cambou, J., Scarabin, P., Bara, L., Green, F. & Cambien, F. (1996) Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. Circulation, 93, 440-449.
6. Blake, G.J., Schmitz, C., Lindpaintner, K. & Ridker, P.M. (2001) Mutation in the promoter region of the β-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. European Heart Journal, 22, 2262-2266.
7. Carter, A.M., Catto, A.J., Bamford, J.M. & Grant, P.J. (1997) Gender-specific associations of the fibrinogen Bβ 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 589-594.
8. Carty, C.L., Cushman, M., Jones, D., Lange, L.A., Hindorff, L.A., Rice, K., Jenny, N.S., Durda, J.P., Walston, J., Carlson, C.S., Nickerson, D., Tracy, R.P. & Reiner, A.P. (2008) Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. Thrombosis and Haemostasis, 99, 388-395.
9. Chen, Y., Torrini, A., Excoffier, L., Santachiara-Benerecetti, A.S. & Wallace, D.C. (1995) Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. American Journal of Human Genetics, 57, 133-149.
10. Chung, D.W. & Davie, E.W. (1984) Gamma and gamma'chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry, 23, 4232-4236.
11. Cook, D.G., Cappuccio, F.P., Atkinson, R.W., Wicks, P.D., Chitolie, A., Nakandakare, E.R., Sagnella, G.A. & Humphries, S.E. (2001) Ethnic differences in fibrinogen levels: the role of environmental factors and the β-fibrinogen gene. American Journal of Epidemiology, 153, 799-806.
12. De Lange, Z., Pieters, M., Jerling, J.C., Kruger, A. & Rijken, D.C. (2012) Plasma clot lysis time and its association with cardiovascular risk factors in black Africans. PLoS One, 7, e48881.
13. Dehghan, A., Yang, Q., Peters, A., Basu, S., Bis, J.C., Rudnicka, A.R., Kavousi, M., Chen, M., Baumert, J., Lowe, G.D.O., McKnight, B., Tang, W., De Maat, M., Larson, M.G., Eyhermendy, S., McArdle, W.L., Lumley, T., Pankow, J.S., Hofman, A., Massaro, J.M., Rivadeneira, F., Kolz, M., Taylor, K.D., Van Duijn, C.M., Kathiresan, S., Illig, T., Aulchenko, Y.S., Volcik, K.A., Johnson, A.D., Uitterlinden, A.G., Tofler, G.H., Gieger, C., Wellcome Trust Case Control Consortium, Psaty, B.M., Couper, D.J., Boerwinkle, E., Koenig, W., O'Donnell, C.J., Witteman, J.C., Strachan, D.P., Smith, N.L. & Folsom, A.R. (2009) Association of novel genetic loci with circulating fibrinogen levels: a genome-wide association study in six population-based cohorts: Dehghan genome-wide association study on fibrinogen. Circulation. Cardiovascular Genetics, 2, 125-133.
14. Folsom, A.R., Wu, K.K., Conlan, M.G., Finch, A., Davis, C.E., Marcucci, G., Sorlie, P.D. & Szklo, M. (1992) Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethnicity & Disease, 2, 35-46.
15. Francis, C.W., Marder, V.J. & Martin, S.E. (1980) Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen. Journal of Biological Chemistry, 255, 5599-5604.
16. Freeman, M.S., Mansfield, M.W., Barrett, J.H. & Grant, P.J. (2002) Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 506-510.
17. Friedlander, Y., Elkana, Y., Sinnreich, R. & Kark, J.D. (1995) Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study. American Journal of Human Genetics, 56, 1194-1206.
18. Green, F.R. (2001) Fibrinogen polymorphisms and atherothrombotic disease. Annals of the New York Academy of Sciences, 936, 549-559.
19. Iso, H., Folsom, A.R., Winkelmann, J.C., Koike, K., Harada, S., Greenberg, B., Sato, S., Shimamoto, T., Iida, M. & Komachi, Y. (1995) Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thrombosis and Haemostasis, 73, 106-111.
20. Jacquemin, B., Antoniades, C., Nyberg, F., Plana, E., Müller, M., Greven, S., Salomaa, V., Sunyer, J., Bellander, T., Chalamandaris, A., Pistelli, R., Koenig, W. & Peters, A. (2008) Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. Journal of the American College of Cardiology, 52, 941-952.
21. Jeff, J.M., Brown-Gentry, K. & Crawford, D.C. (2012) Replication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination Survey. Thrombosis and Haemostasis, 107, 458-467.
22. Kain, K., Blaxill, J.M., Catto, A.J., Grant, P.J. & Carter, A.M. (2002) Increased fibrinogen levels among South Asians versus whites in the United Kingdom are not explained by common polymorphisms. American Journal of Epidemiology, 156, 174-179.
23. Kaptoge, S., White, I.R., Thompson, S.G., Wood, A.M., Lewington, S., Lowe, G.D.O. & Danesh, J. (2007) Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154, 211 adults in 31 prospective studies: the fibrinogen studies collaboration. American Journal of Epidemiology, 166, 867-879.
24. Keavney, B., Danesh, J., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R. & Collins, R. (2006) Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. International Journal of Epidemiology, 35, 935-943.
25. Lange, L.A., Reiner, A.P., Carty, C.L., Jenny, N.S., Cushman, M. & Lange, E.M. (2008) Common genetic variants associated with plasma fibin D-dimer concentration in older European- and African-American adults. Journal of Thrombosis and Haemostasis, 6, 654-659.
26. Lim, B.C.B., Ariëns, R.A.S., Carter, A.M., Weisel, J.W. & Grant, P.J. (2003) Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet, 361, 1424-1431.
27. Lisman, T., De Groot, P.G., Meijers, J.C.M. & Rosendaal, F.R. (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood, 105, 1102-1105.
28. Liu, Y., Saha, N., Heng, C.K., Hong, S. & Low, P.S. (2001) Fibrinogen genotypes (α and β) are associated with plasma fibrinogen levels in Chinese. Journal of Medical Genetics, 38, e31.
29. Lovely, R.S., Yang, Q., Massaro, J.M., Wang, J., D'Agostino, R.B., O'Donnell, C.J., Shannon, J. & Farrell, D.H. (2011) Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 2345-2352.
30. Mannila, M.N., Eriksson, P., Lundman, P., Samnegård, A., Boquist, S., Ericsson, C., Tornvall, P., Hamsten, A. & Silveira, A. (2005) Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thrombosis and Haemostasis, 93, 570-577.
31. Mannila, M.N., Eriksson, P., Ericsson, C., Hamsten, A. & Silveira, A. (2006) Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction. Thrombosis and Haemostasis, 95, 420-427.
32. Mannila, M.N., Lovely, R.S., Kazmierczak, S.C., Eriksson, P., Samnegård, A., Farrell, D.H., Hamsten, A. & Silveira, A. (2007) Elevated plasma fibrinogen γ' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. Journal of Thrombosis and Haemostasis, 5, 766-773.
33. Pieters, M. & Vorster, H.H. (2008) Nutrition and hemostasis: a focus on urbanization in South Africa. Molecular Nutrition & Food Research, 52, 164-172.
34. Pieters, M., De Maat, M.P.M., Jerling, J.C., Hoekstra, T. & Kruger, A. (2011) Fibrinogen concentration and its role in CVD risk in black South Africans - effect of urbanisation. Thrombosis and Haemostasis, 106, 448-456.
35. Pieters, M., Kotze, R.C., Jerling, J.C., Kruger, A. & Ariëns, R.A.S. (2013) Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood, 121, 3254-3260.
36. Reed, T., Tracy, R.P. & Fabsitz, R.R. (1994) Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clinical Genetics, 45, 71-77.
37. Reiner, A.P., Carty, C.L., Carlson, C.S., Wan, J.Y., Rieder, M.J., Smith, J.D., Rice, K., Fornage, M., Jaquish, E., Williams, O.D., Tracy, R.P., Lewis, C.E., Siscovick, D.S., Boerwinkle, E. & Nickerson, D.A. (2006) Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels; the Coronary artery risk development in young adults (CARDIA) study. Journal of Thrombosis and Haemostasis, 4, 1279-1287.
38. Ryan, A.W., Hughes, D.A., Tang, K., Kelleher, D.P., Ryan, T., McManus, R. & Stoneking, M. (2009) Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus. European Journal of Human Genetics, 17, 219-227.
39. Sanger, F., Nicklen, S. & Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, 74, 5463-5467.
40. Standeven, K.F., Grant, P.J., Carter, A.M., Scheiner, T., Weisel, J.W. & Ariëns, R.A.S. (2003) Functional analysis of the fibrinogen AαThr312Ala polymorphism: effects on fibrin structure and function. Circulation, 107, 2326-2330.
41. Teo, Y.Y., Small, K.S. & Kwiatkowski, D.P. (2010) Methodological challenges of genome-wide association analysis in Africa. Nature Reviews Genetics, 11, 149-160.
42. Uitte de Willige, S., De Visser, M.C.H., Houwing-Duistermaat, J.J., Rosendaal, F.R., Vos, H.L. & Bertina, R.M. (2005) Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ' levels. Blood, 106, 4176-4183.
43. Uitte de Willige, S., Pyle, M.E., Vos, H.L., De Visser, M.C.H., Lally, C., Dowling, N.F., Hooper, W.C., Bertina, R.M. & Austin, H. (2009) Fibrinogen gamma gene 3'-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population. Thrombosis and Haemostasis, 101, 1078-1084.
44. Undas, A. & Zeglin, M. (2006) Fibrin clot properties and cardiovascular disease. Vascular Disease Prevention, 3, 99-106.
45. Van der Bom, J.G., De Maat, M.P.M., Bots, M.L., Haverkate, F., De Jong, P.T.V.M., Hofman, A., Kluft, C. & Grobbee, D.E. (1998) Elevated plasma fibrinogen: cause or consequence of cardiovascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 621-625.
46. Van't Hooft, F.M., Von Bahr, S.J.F., Silveira, A., Iliadou, A., Eriksson, P. & Hamsten, A. (1999) Two common, functional polymorphisms in the promoter region of the β fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 3063-3070.
47. Verschuur, M., De Jong, M., Felida, L., De Maat, M.P.M. & Vos, H.L. (2005) A hepatocyte nuclear factor-3 site in the fibrinogen β promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. The Journal of Biological Chemistry, 280, 16763-16771.
48. Vorster, H.H., Jerling, J.C., Steyn, K., Badenhorst, C.J., Slazus, W., Venter, C.S., Jooste, P.L. & Bourne, L.T. (1998) Plasma fibrinogen of black South Africans: the BRISK study. Public Health Nutrition, 1, 169-176.
49. Wassel, C.L., Lange, L.A., Keating, B.J., Taylor, K.C., Johnson, A.D., Palmer, C., Ho, L.A., Smith, N.L., Lange, E.M., Li, Y., Yang, Q., Delaney, J.A., Tang, W., Tofler, G., Redline, S., Taylor, H.A., Wilson, J.G., Tracy, R.P., Jacobs, D.R., Folsom, A.R., Green, D., O'Donnell, C.J. & Reiner, A.P. (2011) Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe). Blood, 117, 268-275.
50. Wypasek, E., Stępień, E., Kot, M., Plicner, D., Kapelak, B., Sadowski, J. & Undas, A. (2012) Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting. Inflammation, 35, 429-435.